Abstract
A number of recent studies have reported the detection of the ubiquitous human polyomavirus, JC virus (JCV), in samples derived from several types of neural as well as non-neural human tumors. The human neurotropic JCV was first identified as the etiologic agent of the fatal demyelinating disease, progressive multifocal leukoencephalopathy, which usually occurs in individuals with defects in cell-mediated immunity, including AIDS. However, upon mounting evidence of the oncogenic potential of the viral regulatory protein, T-antigen, and JCV's oncogenecity in a broad range of animal models, studies were initiated to determine its potential involvement in human carcinogenesis. Initially, the most frequently observed tumors in rodent models, including medulloblastoma, astrocytoma, glioblastoma, and other neural-origin tumors were analysed. These studies were followed by analysis of non-neural tumors such as colorectal carcinomas. In a subset of each tumor type examined, JC viral genomic DNA sequences could be detected by PCR and confirmed by Southern blot hybridization or direct sequencing. In a smaller subset of the tumors, the expression of T-antigen was observed by immunohistochemical analysis. Owing to the established functions of T-antigen including its ability to interact with tumor suppressor proteins such as Rb and p53, and its ability to influence chromosomal stability, potential mechanisms of JCV T-antigen-mediated cellular dysregulation are discussed. Further, as increasing evidence suggests that T-antigen is not required for maintenance of a transformed phenotype, a hit-and-run model for T-antigen-induced transformation is proposed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akatani K, Imai M, Kimura M, Nagashima K and Ikegami N . (1994). J. Med. Virol., 43, 13–19.
Arrington AS and Butel JS . (2001). Human Polyomaviruses: Molecular and Clinical Perspectives, Khalili K, Stoner GL (eds). Wiley-Liss: New York, NY.
Assouline JG and Major EO . (1991). J. Virol., 65, 1002–1006.
Atwood WJ, Amemiya K, Traub R, Harms J and Major EO . (1992). Virology, 190, 716–723.
Baron-Van Evercooren A, Jensen NA, Wyss MT, Cuzin F, Rassoulzadegan M, Brucher JM and Baron H . (1992). Lab. Invest., 66, 39–53.
Berger JR and Concha M . (1995). J. Neurovirol., 1, 5–18.
Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F and Girones R . (2001). J. Virol., 75, 10290–10299.
Boldorini R, Caldarelli-Stefano R, Monga G, Zocchi M, Mediati M, Tosoni A and Ferrante P . (1998). J. Neurovirol., 2, 242–245.
Bollag B, Chuke WF and Frisque RJ . (1989). J. Virol., 63, 863–872.
Brun A and Jonsson N . (1984). Cancer, 53, 1714–1717.
Caldarelli-Stefano R, Boldorini R, Monga G, Meraviglia E, Zorini EO and Ferrante P . (2000). Hum. Pathol., 3, 394–395.
Castaigne P, Rondot P, Escourolle R, Ribadeau Dumas J-L, Cathala F and Hauw J-J . (1974). Rev. Neurol. (Paris), 130, 379–392.
Corallini A, Tognon M, Negrini M and Barbanti-Brodano G . (2001). Human Polyomaviruses: Molecular and Clinical Perspectives, Khalili K, Stoner GJ (eds).. Wiley-Liss: New York, NY.
Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A and Khalili K . (2002). Oncogene, 21, 5574–5581.
Del Valle L, Delbue S, Gordon J, Enam S, Croul S, Ferrante P and Khalili K . (2002b). Neurology, 58, 895–900.
Del Valle L, Enam S, Lara C, Ortiz-Hidalgo C, Katsetos CD and Khalili K . (2002c). Clin. Cancer Res., 8, 3332–3340.
Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis J, Katsetos CD, Croul S and Khalili K . (2001). Cancer Res., 61, 4287–4293.
Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakoupoulou M, Katsetos CD and Khalili K . (2002a). J. Natl. Cancer Inst., 94, 267–273.
Del Valle L, Wang JY, Lassak A, Peruzzi F, Croul S, Khalili K and Reiss K . (2002d). J. Neurovirol., (Suppl. 2) 8, 138–147
De Mattei M, Martini F, Corallini A, Gerosa M, Scotlandi K, Carinci P, Barbanti-Brodano G and Tognon M . (1995). Int. J. Cancer, 61, 756–760.
Devireddy LR, Kuman KU, Pater MM and Pater A . (1996). J. Med. Virol., 49, 205–211.
Dyson N, Bernards R, Friend SH, Gooding LR, Hassel JA, Major EO, Pipas JM, Van Dyke T and Harlow E . (1990). J. Virol., 64, 1353–1356.
Dyson N, Buchkovich K, Whyte P and Harlow E . (1989). Cell, 58, 249–255.
Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP and Khalili K . (2002). Cancer Res., 62, 7093–7101.
Franks RR, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL and Khalili K . (1996). Oncogene, 12, 2573–2578.
Frisque RJ, Bream GL and Cannella MT . (1984). J. Virol., 51, 458–469.
Frye S, Trebst C, Dittmer U, Petry H, Bodemer M, Hunsmann G, Weber T and Luke W . (1997). J. Virol. Methods, 63, 81–92.
Gan DD, Reiss K, Gorrill T, Del Valle L, Croul S, Giordano A, Fishman P and Khalili K . (2001). Oncogene, 20, 4864–4870.
Gordon J, Del Valle L, Otte J and Khalili K . (2000). Oncogene, 19, 4840–4846.
Haas S, Haque NS, Beggs AH, Khalili K, Knobler RL and Small J . (1994). Virology, 202, 89–96.
Haggerty S, Walker DL and Frisque RJ . (1989). J. Virol., 63, 2180–2190.
Hara K, Sugimoto C, Kitamura T, Aoki N, Taguichi F and Yogo Y . (1998). J. Virol., 72, 5335–5342.
Kitamura T, Kunitkake T, Guo J, Tominaga T, Kawabe K and Yogo Y . (1994). J. Clin. Microbiol., 32, 2359–2363.
Krynska B, Del Valle L, Gordon J, Otte J, Croul S and Khalili K . (2000). Virology, 274, 65–74.
Krynska B, Del Valle L, Croul S, Gordon J, Katsetos K, Carbone M, Giordano A and Khalili K . (1999a). Proc. Natl. Acad. Sci. USA, 96, 11 519–11 524.
Krynska B, Otte J, Franks R, Khalili K and Croul S . (1999b). Oncogene, 18, 39–46.
Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV and Boland CR . (1999). Proc. Natl. Acad. Sci. USA, 96, 7484–7489.
Lazutka JR, Neel JV, Major EO, Dedonyte V, Mierauskine J, Slapsyte G and Kesminieni A . (1996). Cancer Lett., 109, 177–183.
Leon SP, Zhu L and Black P McL . (1994). Neurosurgery, 34, 708–722.
London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM and Ohashi T . (1978). Science, 201, 1246–1249.
Ludlow JW and Skuse GR . (1995). Virus Res., 35, 113–121.
Lynch KJ, Haggerty S and Frisque RJ . (1994). Virology, 204, 819–822.
Major EO, Amemiya K, Tornatore CS, Houff SA and Berger JR . (1992). Clin. Microbiol. Rev., 5, 49–73.
Major EO, Miller AI, Mourrain P, Traub RG, De Widt E and Sever J . (1985). Proc. Natl. Acad. Sci. USA, 82, 1257–1261.
Major EO and Vacante DA . (1989). J. Neuropathol. Exp. Neurol., 48, 425–436.
Major EO, Vacante DA, Traub RG, London WT and Sever JL . (1987). J Virol., 61, 1435–1441.
Mandl C, Walker DL and Frisque RJ . (1987). J. Virol., 61, 755–763.
Matsuda M, Yasui K, Nagashima K and Mori W . (1987). J. Natl. Cancer Inst., 79, 585–591.
Molenaar WM and Trojanowski JQ . (1994). Crit. Rev. Oncol. Hematol., 17, 1–25.
Monaco MCG, Jensen PN, Hou J, Durham LC and Major EO . (1998). J. Virol., 9918–9923.
Nagashima K, Yasui K, Kimura J, Washizu M, Yamaguchi K and Mori W . (1984). Am. J. Pathol., 116, 455–463.
Neel JV, Major EO, Awa AA, Glover T, Burgess A, Troub R, Curfman B and Satoh C . (1996). Proc. Natl. Acad. Sci. USA, 93, 2690–2695.
Ohsumi S, Motoi M and Ogawa K . (1986). Acta. Pathol. Jpn., 36, 815–825.
Padgett BL and Walker DL . (1973). J. Infect. Dis., 127, 467–470.
Price RW . (1996). Lancet, 348, 445–452.
Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K and Andrews D . (1996). Proc. Natl. Acad. Sci. USA, 93, 7352–7357.
Riccardiello L, Chang DK, Laghi L, Goel A, Chang CL and Boland R . (2001). J. Virol., 75, 1996–2001.
Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE and Boland CR . (2000). Gastroenterology, 119, 1228–1235.
Richardson EP . (1961). New Engl. J. Med., 265, 815–823.
Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K and Khalili K . (2001). J Virol, 75, 1476–1486.
Shinohara T, Nagashima K and Major EO . (1997). Virology, 2, 269–277.
Sima AAF, Finkelstein SD and MacLachlan DR . (1983). Ann. Neurol., 14, 183–188.
Small JA, Scangos GA, Cork L, Jay G and Khoury G . (1986a). Cell, 46, 13–18.
Small JA, Khoury G, Jay G, Howley PM and Scangos GA . (1986b). Proc. Natl. Acad. Sci. USA, 83, 8288–8292.
Theile M and Grabowski G . (1990). Arch. Virol., 113, 221–233.
Vacante DA, Traub R and Major EO . (1989). Virology, 170, 353–361.
Walker DL and Padgett BL . (1983). Prog. Clin. Biol. Res., 105, 99–106.
Walker DL, Padgett BL, Zu Rhein GM, Albert AE and Marsh RF . (1973). Science, 181, 674–676.
Woodruff JM, Kourea HP, Louis DN and Scheithauer BW . (2000). Pathology and Genetics of Tumors of the Nervous System, Kleihues P, Cavenee WK (eds.). IARC Press: Lyon, France.
Wroblewska Z, Wellish M and Gilden D . (1980). Arch. Virol., 65, 141–148.
Zu Rhein GM . (1983). Polyomaviruses and Human Neurological Diseases. Alan R. Liss, Inc.: New York, NY, pp. 205–221.
Zu Rhein GM and Varakis JN . (1979). Natl. Cancer Inst. Monogr., 51, 205–208.
Acknowledgements
We thank past and present members of the Center for Neurovirology and Cancer Biology for their insightful discussion, and sharing of ideas of reagents. We also thank C Schriver for preparation of this manuscript. This work was made possible by grants awarded by NIH to JG and KK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
This article is cited by
-
Progressive multifocal leukoencephalopathy in patients with chronic kidney disease
Neurological Sciences (2024)
-
Unusually high incidence of polyomavirus JC infection in the higher grade of colorectal cancer tissues in Taiwan
European Journal of Medical Research (2022)
-
Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement
Journal of NeuroVirology (2018)
-
The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis
Infectious Agents and Cancer (2017)
-
Detection of Malawi polyomavirus sequences in secondary lymphoid tissues from Italian healthy children: a transient site of infection
Virology Journal (2016)